Clinical trials: Indication for Prostate Biopsy Due to Suspected Prostate Cancer
- Condition Indication for Prostate Biopsy Due to Suspected Prostate Cancer
- Funder type Industry (pharma, biotech, devices)
Indication for Prostate Biopsy Due to Suspected Prostate Cancer
PRospective Prostate biOmarker Study
Correlation of a glycoprotein panel with prostate biopsy outcome and PCa aggressiveness
- Trial name
- PROPOSe (NCT03565289)
- Testing
- Blood sample collection
- Where
- 11 sites in Austria, Denmark and 1 more
- Volunteers
- 455 people
- Sponsor
- ProteoMediX AG